Visceral fat, which surrounds internal organs, is particularly dangerous
1-7 Semaglutide, found in Ozempic and Wegovy, can be added to existing treatment regimens to improve glycemic control and induce weight loss
Additionally, GLP-1 receptors in the hypothalamus interact with key appetite-regulating neuropeptides, including pro-opiomelanocortin (POMC) and neuropeptide Y (NPY)
Chlorpromazine, quinidine, clofazimine, ketoconazole, oral contraceptives, and chemotherapeutic agents (particularly busulfan) may also produce oral pigmentation
In the meantime, manufacturers like Novo Nordisk, maker of the GLP-1 Wegovy (available as an injection or pill), and Eli Lilly, which makes both the injectable drug Zepbound and the new Foundayo GLP-1 pill, have also created discounted programs for employers and/or self-paying customers